Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-130-01)
Recall Number: D-0180-2020
Firm: Dr. Reddy's Laboratories, Inc.
Classification: Class II
Status: Completed
Report Date: 20191113
Initiation Date: 20191001
Termination Date:
Reason for Recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Product Description
Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-130-01)